Patent ID: 8563591

Claim:
A compound having the formula the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein X represents C; Y represents C; L represents a methyl or a direct bond; Z 1 represents a direct bond and Z 2 represents C 2 alkyl- or —CH 2 —CH═, or Z 1 represents a C 1 alkyl- or —CH═ and Z 2 represents C 1 alkyl- or —CH═, or Z 1 represents C 2 alkyl- or —CH 2 —CH═ and Z 2 represents a direct bond; R 1 represents hydrogen, halo, cyano, amino, phenyl, hydroxy, C 1-4 alkyloxycarbonyl, —O—(C═O)—C 1-4 alkyl, hydroxycarbonyl, NR 3 R 4 or C 1-4 alkyl wherein said C 1-4 alkyl or —O—(C═O)—C 1-4 alkyl are optionally substituted with one or more substituents selected from halo, hydroxycarbonyl, phenyl, C 1-4 alkyloxy or NR 5 R 6 or R 1 represents C 1-4 alkyloxy- optionally substituted with one or more substituents selected from halo, hydroxycarbonyl, phenyl, C 1-4 alkyloxy or NR 7 R 8 ; R 2 represents hydrogen, halo, C 1-4 alkyl or C 1-4 alkyloxy-; R 3 and R 4 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-; R 5 and R 6 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-; R 7 and R 8 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-; and A represents phenyl.